Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. (INTI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INTI · as of Jun 9, 2026
Key Statistics
Explore Inhibitor Therapeutics, Inc. Data
inti stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
inti competitorsINTI
BETRF
CHMMF
CUBT
DVHGF
LIANYStock Performance
Full HistoryAbout Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments …
what is inhibitor therapeutics, inc. · inti stock overview · inhibitor therapeutics, inc. company profile · who is inhibitor therapeutics, inc. ceo · inti OTC · inhibitor therapeutics, inc. headquarters · inhibitor therapeutics, inc. business segments
About Stock Overview & Key Data
Inhibitor Therapeutics, Inc. (INTI) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 13, 2013. As of the latest trading session, INTI stock price is $0.08, with a market capitalization of $14.6M. The stock has returned +57.15% over the past 12 months and +88.58% year-to-date.
In fiscal year 2025, Inhibitor Therapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Inhibitor Therapeutics, Inc. (INTI) stock price is $0.08. The stock is traded on OTC under the ticker symbol INTI. The 52-week range is $0.04 – $0.12.